Optimal Duration of MRI Follow-up to Safely Identify Middle Ear Residual Cholesteatoma

References

1. 1.↵
   1. Lingam RK,
   2. Bassett P

   . A meta-analysis on the diagnostic performance of non-echoplanar diffusion-weighted imaging in detecting middle ear cholesteatoma: 10 years on. Otol Neurotol 2017;38:521–28 doi:10.1097/MAO.0000000000001353 pmid:28195998

   CrossRefPubMed
2. 2.↵
   1. Bazzi K,
   2. Wong E,
   3. Jufas N, et al

   . Diffusion-weighted magnetic resonance imaging in the detection of residual and recurrent cholesteatoma in children: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol 2019;118:90–96 doi:10.1016/j.ijporl.2018.12.031 pmid:30599286

   CrossRefPubMed
3. 3.↵
   1. Lingam RK,
   2. Khatri P,
   3. Hughes J, et al

   . Apparent diffusion coefficients for detection of postoperative middle ear cholesteatoma on non-echo-planar diffusion-weighted images. Radiology 2013;269:504–10 doi:10.1148/radiol.13130065 pmid:23801772

   CrossRefPubMed
4. 4.↵
   1. Khemani S,
   2. Lingam RK,
   3. Kalan A, et al

   . The value of non-echo planar HASTE diffusion-weighted MR imaging in the detection, localisation and prediction of extent of postoperative cholesteatoma. Clin Otolaryngol 2011;36:306–12 doi:10.1111/j.1749-4486.2011.02332.x pmid:21564557

   CrossRefPubMed
5. 5.↵
   1. Akkari M,
   2. Gabrillargues J,
   3. Saroul N, et al

   . Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:153–58 doi:10.1016/j.anorl.2013.08.002 pmid:24709404

   CrossRefPubMed
6. 6.↵
   1. Gaillardin L,
   2. Lescanne E,
   3. Moriniere S, et al

   . Residual cholesteatoma: prevalence and location: follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis 2012;129:136–40 doi:10.1016/j.anorl.2011.01.009 pmid:21955464

   CrossRefPubMed
7. 7.↵
   1. Horn RJ,
   2. Gratama JW,
   3. van der Zaag-Loonen HJ, et al

   . Negative predictive value of non-echo-planar diffusion weighted MR imaging for the detection of residual cholesteatoma done at 9 months after primary surgery is not high enough to omit second look surgery. Otol Neurotol 2019;40:911–19 doi:10.1097/MAO.0000000000002270 pmid:31219966

   CrossRefPubMed
8. 8.↵
   1. Lecler A,
   2. Lenoir M,
   3. Peron J, et al

   . Magnetic resonance imaging at one year for detection of postoperative residual cholesteatoma in children: is it too early? Int J Pediatr Otorhinolaryngol 2015;79:1268–74 doi:10.1016/j.ijporl.2015.05.028 pmid:26071017

   CrossRefPubMed
9. 9.↵
   1. De Foer B,
   2. Vercruysse JP,
   3. Bernaerts A, et al

   . Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging. Otol Neurotol 2008;29:513–17 doi:10.1097/MAO.0b013e31816c7c3b pmid:18520587

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Pai I,
    2. Crossley E,
    3. Lancer H, et al

    . Growth and late detection of post-operative cholesteatoma on long term follow-up with diffusion weighted magnetic resonance imaging (DWI MRI): a retrospective analysis from a single UK centre. Otol Neurotol 2019;40:638–44 doi:10.1097/MAO.0000000000002188 pmid:31083089

    CrossRefPubMed
11. 11.↵
    1. Yung M,
    2. Tono T,
    3. Olszewska E, et al

    . EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 2017;13:1–8 doi:10.5152/iao.2017.3363 pmid:28059056

    CrossRefPubMed
12. 12.↵
    1. Steens S,
    2. Venderink W,
    3. Kunst D, et al

    . Repeated postoperative follow-up diffusion-weighted magnetic resonance imaging to detect residual or recurrent cholesteatoma. Otol Neurotol 2016;37:356–61 doi:10.1097/MAO.0000000000000985 pmid:26905824

    CrossRefPubMed
13. 13.↵
    1. Lincot J,
    2. Veillon F,
    3. Riehm S, et al

    . Middle ear cholesteatoma: compared diagnostic performances of two incremental MRI protocols including non-echo planar diffusion-weighted imaging acquired on 3T and 1.5T scanners. J Neuroradiol 2015;42:193–201 doi:10.1016/j.neurad.2014.02.003 pmid:25015879

    CrossRefPubMed
14. 14.↵
    1. Lips LM,
    2. Nelemans PJ,
    3. Theunissen FM, et al

    . The diagnostic accuracy of 1.5 T versus 3 T non-echo-planar diffusion-weighted imaging in the detection of residual or recurrent cholesteatoma in the middle ear and mastoid. J Neuroradiol 2020;47:433–40 doi:10.1016/j.neurad.2019.02.013 pmid:30951771

    CrossRefPubMed
15. 15.↵
    1. Gristwood RE,
    2. Venables WN

    . Growth rate and recurrence of residual epidermoid cholesteatoma after tympanoplasty. Clin Otolaryngol Allied Sci 1976;1:169–82 doi:10.1111/j.1365-2273.1976.tb00869.x pmid:1031660

    CrossRefPubMed
16. 16.↵
    1. Venail F,
    2. Bonafe A,
    3. Poirrier V, et al

    . Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma. AJNR Am J Neuroradiol 2008;29:1363–68 doi:10.3174/ajnr.A1100 pmid:18417598

    Abstract/FREE Full Text
17. 17.↵
    1. Geven LI,
    2. Mulder JJ,
    3. Graamans K

    . Giant cholesteatoma: recommendations for follow-up. Skull Base 2008;18:353–59 doi:10.1055/s-0028-1086054 pmid:19240835

    CrossRefPubMed
18. 18.↵
    1. Choi DL,
    2. Gupta MK,
    3. Rebello R, et al

    . Cost-comparison analysis of diffusion weighted magnetic resonance imaging (DWMRI) versus second look surgery for the detection of residual and recurrent cholesteatoma. J Otolaryngol Head Neck Surg 2019;48:58 doi:10.1186/s40463-019-0384-1 pmid:31699154

    CrossRefPubMed